Sunshine Biopharma (SBFM)

$2.11 -0.07 (-3.21%)
Market Cap 1.06M
Revenue (ttm) 36.31M
Net Income (ttm) -5.98M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -16.47%
Debt to Equity Ratio 0.00
Volume 51,100
Avg Vol 2,013,058
Day's Range N/A - N/A
Shares Out 501,000.00
Stochastic %K 37%
Beta 1.13
Analysts Sell
Price Target $56.00

Company Profile

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 954 330 0684
Address:
333 Las Olas Way, CU4 Suite 433, Fort Lauderdale, United States
StreakGeek
StreakGeek Jul. 2 at 5:16 PM
$TBH $SMX $SCYX $SBFM connecting
0 · Reply
TNNStockAnalysisNews
TNNStockAnalysisNews Jul. 1 at 9:33 PM
Today’s Biggest Stock Gainers — Wednesday, July 1, 2026: The Full Breakdown $LFVN 📈 Premarket Gain: +22.69% to $11.57 | Volume: 143,854 $GXAI +68.07% $LOBO +50.00% $QUCY +23.32% $SBFM +20.08% https://truthsandnews.com/markets/top-gaining-stocks-today-wednesday-july-1-2026
0 · Reply
contra7
contra7 Jun. 30 at 11:57 PM
$SBFM https://www.sandoz.com/us-fda-accepts-sandoz-applications-proposed-house-development-generic-tirzepatide-glp-1s/ This is called “clearing the deck” before a market moving announcement 📣
3 · Reply
Jahubba
Jahubba Jun. 30 at 10:08 PM
$SBFM How disappointing!
3 · Reply
mimiwor
mimiwor Jun. 30 at 7:47 PM
$SBFM He is crying lol
0 · Reply
Masterrunner
Masterrunner Jun. 30 at 6:43 PM
$SBFM Before investing in this turd, look at this impressive graph and move on.
0 · Reply
Jahubba
Jahubba Jun. 30 at 12:18 AM
$SBFM Maybe tomorrow for buyout. Got to keep believing. !!
0 · Reply
FatCatFenix
FatCatFenix Jun. 29 at 12:38 PM
$SBFM The DEF 14C didn’t create a blackout—it created a 20-day waiting period. That period has now expired, so today is the first business day the amended Series C warrants can legally become effective and be exercisable… still no news about the B warrants. Expect a pump and afterhours movement that will allow these to land in the money. Remember to sell on that pop and/or on HALT DAYS!!! This will likely be the only moment you’ll come out on top before the OS gets heavily diluted.
1 · Reply
hotslots
hotslots Jun. 28 at 8:54 PM
$SBFM last time i said this it worked so here goes nothing! Just need 700% from here
0 · Reply
Luka_Brasi
Luka_Brasi Jun. 27 at 11:45 PM
$SBFM These guys said they cured cancer. What happened to that?
0 · Reply
Latest News on SBFM
Sunshine Biopharma receives Canadian approval for generic Arimidex

2026-06-25T12:20:47.000Z - 9 days ago

Sunshine Biopharma receives Canadian approval for generic Arimidex

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)

Jun 25, 2026, 8:00 AM EDT - 9 days ago

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)

Sunshine Biopharma announces Canadian approval for Rivaroxaban

2026-06-01T12:23:56.000Z - 4 weeks ago

Sunshine Biopharma announces Canadian approval for Rivaroxaban

Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)

Jun 1, 2026, 8:00 AM EDT - 4 weeks ago

Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)

R

Sunshine Biopharma Inc trading halted, news pending

2026-05-29T23:55:22.000Z - 5 weeks ago

Sunshine Biopharma Inc trading halted, news pending

Sunshine Biopharma issued U.S. patent for coronavirus treatment tech

2026-05-29T13:11:09.000Z - 5 weeks ago

Sunshine Biopharma issued U.S. patent for coronavirus treatment tech

Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology

May 29, 2026, 8:00 AM EDT - 5 weeks ago

Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology

Sunshine Biopharma announces 1-for-10 reverse split of its common stock

2026-05-28T14:49:55.000Z - 5 weeks ago

Sunshine Biopharma announces 1-for-10 reverse split of its common stock

Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing

May 28, 2026, 9:00 AM EDT - 5 weeks ago

Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing

Sunshine announces approval of generic amoxicillin formulation for Canada

2026-05-21T11:17:11.000Z - 6 weeks ago

Sunshine announces approval of generic amoxicillin formulation for Canada

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin

May 21, 2026, 7:00 AM EDT - 6 weeks ago

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin

3 Penny Stocks to Watch Now, 5/19/26

2026-05-19T16:21:43.000Z - 6 weeks ago

3 Penny Stocks to Watch Now, 5/19/26

AIIO GOVX

Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering

May 19, 2026, 12:05 PM EDT - 6 weeks ago

Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering

Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering

May 18, 2026, 12:15 PM EDT - 6 weeks ago

Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering

Why Is Penny Stock Sunshine Biopharma (SBFM) Up Today?

2026-05-18T12:55:34.000Z - 6 weeks ago

Why Is Penny Stock Sunshine Biopharma (SBFM) Up Today?

Sunshine Biopharma files to sell 5.825M common units

2026-05-12T21:20:04.000Z - 7 weeks ago

Sunshine Biopharma files to sell 5.825M common units

Sunshine Biopharma reports FY25 EPS ($1.44) vs. ($7.32) last year

2026-04-06T12:53:12.000Z - 3 months ago

Sunshine Biopharma reports FY25 EPS ($1.44) vs. ($7.32) last year

Sunshine Biopharma expects to reduce expenses by $2M-$3M in 2026

2026-04-06T12:52:43.000Z - 3 months ago

Sunshine Biopharma expects to reduce expenses by $2M-$3M in 2026

Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year

Apr 6, 2026, 8:30 AM EDT - 3 months ago

Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year

Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)

Oct 28, 2025, 2:10 PM EDT - 8 months ago

Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)

Sunshine Biopharma’s Nora Pharma receives Health Canada approval for domperidone

2025-10-28T11:50:45.000Z - 8 months ago

Sunshine Biopharma’s Nora Pharma receives Health Canada approval for domperidone

Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea

Oct 28, 2025, 7:45 AM EDT - 8 months ago

Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea

Sunshine Biopharma announces commercial launch of doxycycline in Canada

2025-10-20T11:50:37.000Z - 9 months ago

Sunshine Biopharma announces commercial launch of doxycycline in Canada

Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline

Oct 20, 2025, 7:45 AM EDT - 9 months ago

Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline

Sunshine Biopharma’s Nora Pharma launches pravastatin

2025-10-16T11:50:20.000Z - 9 months ago

Sunshine Biopharma’s Nora Pharma launches pravastatin

Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin

Oct 16, 2025, 7:45 AM EDT - 9 months ago

Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin

Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)

Oct 14, 2025, 10:45 AM EDT - 9 months ago

Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)

Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)

Oct 14, 2025, 8:50 AM EDT - 9 months ago

Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)

Sunshine Biopharma allocates $5M for investment in bitcoin

2025-10-14T11:20:53.000Z - 9 months ago

Sunshine Biopharma allocates $5M for investment in bitcoin

Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience

Oct 14, 2025, 7:00 AM EDT - 9 months ago

Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience

Sunshine Biopharma, University of Arizona develop series of protease inhibitors

2025-10-09T12:26:07.000Z - 9 months ago

Sunshine Biopharma, University of Arizona develop series of protease inhibitors

Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections

Oct 9, 2025, 8:00 AM EDT - 9 months ago

Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections

Sunshine Biopharma’s Nora Pharma launches NIOPEG

2025-07-02T12:26:57.000Z - 1 year ago

Sunshine Biopharma’s Nora Pharma launches NIOPEG

Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market

Jul 2, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market

Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market

Jun 11, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market

Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year

May 15, 2025, 4:15 PM EDT - 1 year ago

Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market

May 6, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion

Apr 21, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

Apr 3, 2025, 10:50 AM EDT - 1 year ago

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

Apr 2, 2025, 1:20 PM EDT - 1 year ago

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer

Apr 2, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

Apr 1, 2025, 5:09 PM EDT - 1 year ago

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada

Mar 24, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market

Mar 10, 2025, 9:00 AM EDT - 1 year ago

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market

Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

Jan 21, 2025, 8:00 AM EST - 1 year ago

Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer

Jan 15, 2025, 8:00 AM EST - 1 year ago

Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer

Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus

Dec 9, 2024, 7:30 AM EST - 1 year ago

Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus

Sunshine Biopharma Launches a New Generic Prescription Drug

Dec 4, 2024, 4:05 PM EST - 1 year ago

Sunshine Biopharma Launches a New Generic Prescription Drug

Sunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma

Dec 2, 2024, 8:00 AM EST - 1 year ago

Sunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma

Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%

Nov 6, 2024, 8:00 AM EST - 1 year ago

Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%

Sunshine Biopharma Launches Two New Generic Prescription Drugs

Sep 26, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Launches Two New Generic Prescription Drugs

Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry

Sep 4, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry

Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada

Aug 26, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada

Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61%

Aug 19, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61%

Sunshine Biopharma Announces Reverse Stock Split

Aug 6, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Announces Reverse Stock Split

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)

Apr 19, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)

Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023

Apr 1, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023

Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering

Feb 15, 2024, 9:15 AM EST - 2 years ago

Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering

Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering

Feb 13, 2024, 9:00 AM EST - 2 years ago

Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering

Sunshine Biopharma Moves Principal Office to New York City

Dec 4, 2023, 8:30 AM EST - 2 years ago

Sunshine Biopharma Moves Principal Office to New York City

Sunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key Acquisition

Nov 13, 2023, 8:30 AM EST - 2 years ago

Sunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key Acquisition

Sunshine Biopharma Receives 180-Day Extension To Achieve Nasdaq Minimum Bid Compliance

Sep 21, 2023, 9:05 PM EDT - 3 years ago

Sunshine Biopharma Receives 180-Day Extension To Achieve Nasdaq Minimum Bid Compliance

Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%

Aug 11, 2023, 8:30 AM EDT - 3 years ago

Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%

Aegis Capital Corp. Acted as Exclusive Placement Agent on a $5.0 Million Private Placement Priced At-the-Market for Sunshine Biopharma, Inc. (NASDAQ:SBFM)

May 16, 2023, 2:15 PM EDT - 3 years ago

Aegis Capital Corp. Acted as Exclusive Placement Agent on a $5.0 Million Private Placement Priced At-the-Market for Sunshine Biopharma, Inc. (NASDAQ:SBFM)

Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-Market

May 16, 2023, 9:58 AM EDT - 3 years ago

Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-Market

Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market

May 12, 2023, 8:00 AM EDT - 3 years ago

Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market

Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%

May 11, 2023, 9:00 AM EDT - 3 years ago

Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%

StreakGeek
StreakGeek Jul. 2 at 5:16 PM
$TBH $SMX $SCYX $SBFM connecting
0 · Reply
TNNStockAnalysisNews
TNNStockAnalysisNews Jul. 1 at 9:33 PM
Today’s Biggest Stock Gainers — Wednesday, July 1, 2026: The Full Breakdown $LFVN 📈 Premarket Gain: +22.69% to $11.57 | Volume: 143,854 $GXAI +68.07% $LOBO +50.00% $QUCY +23.32% $SBFM +20.08% https://truthsandnews.com/markets/top-gaining-stocks-today-wednesday-july-1-2026
0 · Reply
contra7
contra7 Jun. 30 at 11:57 PM
$SBFM https://www.sandoz.com/us-fda-accepts-sandoz-applications-proposed-house-development-generic-tirzepatide-glp-1s/ This is called “clearing the deck” before a market moving announcement 📣
3 · Reply
Jahubba
Jahubba Jun. 30 at 10:08 PM
$SBFM How disappointing!
3 · Reply
mimiwor
mimiwor Jun. 30 at 7:47 PM
$SBFM He is crying lol
0 · Reply
Masterrunner
Masterrunner Jun. 30 at 6:43 PM
$SBFM Before investing in this turd, look at this impressive graph and move on.
0 · Reply
Jahubba
Jahubba Jun. 30 at 12:18 AM
$SBFM Maybe tomorrow for buyout. Got to keep believing. !!
0 · Reply
FatCatFenix
FatCatFenix Jun. 29 at 12:38 PM
$SBFM The DEF 14C didn’t create a blackout—it created a 20-day waiting period. That period has now expired, so today is the first business day the amended Series C warrants can legally become effective and be exercisable… still no news about the B warrants. Expect a pump and afterhours movement that will allow these to land in the money. Remember to sell on that pop and/or on HALT DAYS!!! This will likely be the only moment you’ll come out on top before the OS gets heavily diluted.
1 · Reply
hotslots
hotslots Jun. 28 at 8:54 PM
$SBFM last time i said this it worked so here goes nothing! Just need 700% from here
0 · Reply
Luka_Brasi
Luka_Brasi Jun. 27 at 11:45 PM
$SBFM These guys said they cured cancer. What happened to that?
0 · Reply
Jahubba
Jahubba Jun. 27 at 1:37 AM
$SBFM So Monday buyout? 700 million? Its possible! Maybe more lets hope.
2 · Reply
Masterrunner
Masterrunner Jun. 25 at 4:58 PM
$SBFM I sold all but 1 share at 1.85$ pre-RS (a few weeks ago); which is 18.50$ today. There is nothing they can announce today or ever that will bring the SP that high. NOTHING! Trade this turd, don't hold it. NFA!
1 · Reply
MB66
MB66 Jun. 25 at 4:02 PM
$SBFM who just dumped 30K SBFMW at .05!?! 🤬😤
0 · Reply
topstockalerts
topstockalerts Jun. 25 at 3:38 PM
$SBFM keep an eye on the dip
0 · Reply
Dailyfollower
Dailyfollower Jun. 25 at 3:01 PM
$SBFM not yet
0 · Reply
BioTuesdays
BioTuesdays Jun. 25 at 2:45 PM
$SBFM has announced the approval of its generic Anastrozole tablets of 1mg for the treatment of postmenopausal women with hormone receptor-positive breast cancer in the Canadian market. https://biotuesdays.com/2026/06/25/sunshine-receives-canadian-regulatory-approval-for-generic-anastrozole-tablets/
0 · Reply
sbn15
sbn15 Jun. 25 at 2:22 PM
$SBFM
0 · Reply
2pumps1dump
2pumps1dump Jun. 25 at 2:14 PM
$SBFM 🌋
0 · Reply
MamaR
MamaR Jun. 25 at 2:14 PM
$SBFM heating up! 3+
0 · Reply
ProfessorDman1
ProfessorDman1 Jun. 25 at 2:13 PM
$SBFM bingo .. told you gave you this 2.02-2.04 buy idea this morning
0 · Reply
topstockalerts
topstockalerts Jun. 25 at 2:10 PM
$SBFM waking up
0 · Reply
24DV4NC3D
24DV4NC3D Jun. 25 at 1:41 PM
$SBFM ⚡️WHAT DID I SAY?!⚡️ STOCK OF THE DAY - VOLUME >>> GREAT SETUP <<< >>>>> #LISTEN! <<<<< 🎯 XXX% ON TAP >> CONTINUATION LIKELY! << >>>>>>> LISTEN! <<<<<<<
0 · Reply